We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VXRT market cap is 124.31M. The company's latest EPS is USD -0.4743 and P/E is -1.48.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 22k | 675k | 1.36M | 2.1M |
| Operating Income | -29.43M | -31.14M | -25.57M | -23.05M | -17.82M |
| Net Income | -29.31M | -23.92M | -25.14M | -22.55M | -17.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.86M | 4.9M | 892k | 107k | 7.38M |
| Operating Income | -15.79M | -30.17M | -72.75M | -114.59M | -83.35M |
| Net Income | -18.65M | -32.22M | -70.47M | -107.76M | -82.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 175.31M | 153.85M | 129.85M | 122.65M | 105.64M |
| Total Liabilities | 53M | 43.25M | 40.1M | 37.58M | 34.12M |
| Total Equity | 122.31M | 110.6M | 89.75M | 85.07M | 71.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.03M | 152.58M | 221.17M | 153.85M | 91.83M |
| Total Liabilities | 24.08M | 29.18M | 33.64M | 43.25M | 34.03M |
| Total Equity | 12.95M | 123.4M | 187.53M | 110.6M | 57.81M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -65.63M | -94.78M | -24.46M | -41.93M | -56.93M |
| Investing | -36.22M | -20.42M | 25.46M | 23.88M | 28.85M |
| Financing | 8.87M | 17.46M | 1.42M | 15.32M | 15.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.09M | -23.75M | -59.83M | -94.78M | -70.45M |
| Investing | -850k | -1.22M | -49.1M | -20.42M | 43.95M |
| Financing | 15.96M | 138.31M | 125.8M | 17.46M | 15.24M |
| Market Cap | 124.31M |
| Price to Earnings Ratio | -1.48 |
| Price to Sales Ratio | 16.51 |
| Price to Cash Ratio | 3.5 |
| Price to Book Ratio | 2.11 |
| Dividend Yield | - |
| Shares Outstanding | 173.86M |
| Average Volume (1 week) | 1.52M |
| Average Volume (1 Month) | 1.64M |
| 52 Week Change | -12.80% |
| 52 Week High | 1.59 |
| 52 Week Low | 0.53 |
| Spread (Intraday) | 0.02 (2.71%) |
| Company Name | Vaxart Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://vaxart.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
